August 2025. Congratulations to Yingqi Zhao, PhD, who has received an R01 grant, Developing Methods for Advancing the Early Detection of Pancreatic Ductal Adenocarcinoma Leveraging Electronic Medical Records Data, from the National Cancer Institute to advance the early detection of pancreatic ductal adenocarcinoma (PDAC). The project will use electronic medical record data to develop cost-effective strategies for identifying high-risk populations and integrating EMR-derived data with biomarkers to improve early detection of this deadly cancer.
August 2025. Arnold Johnson has joined our group as a Postdoc. Welcome, Arnold!
August 2025. Members of the Zhao group were well represented at JSM in Nashville this year:
- Albert Osom: Developing Performance-Guaranteed Biomarker Combination Rules with Integrated External Information under Practical Constraint
- Yingqi Zhao: Improve Fairness with Shift-Adjusted Neyman–Pearson Classifiers via Single Index Modeling (SACSI)
- Yingqi Zhao (Chair and Organizer) and Yingye Zheng (Organizer) Present the Invited Paper Session "Pioneering New Strategies in Preventive Healthcare: Design and Analysis Innovations"
- Yingye Zheng: Raising the Bar for Launching Biomarker Utility Trial Design with Muti-stage Incidence and Mortality Modeling
June 2025. Congratulations to Albert Osom on winning an honorable mention for his paper "Developing Performance-Guaranteed Biomarker Combination Rules with Integrated External Information under Practical Constraints" from the 2025 JSM Section on Risk Analysis Student Paper Award Competition! His work on developing biomarker-based strategies to improve the early detection of pancreatic cancer is highly impressive. Well done, Albert!
January 2025. Congratulations to Dr. Kehao Zhu on successfully earning his PhD! Well done!
January 2025. The highly anticipated PROSPECT-Lung trial, led by the Alliance for Clinical Trials in Oncology and the SWOG Cancer Research Network, has officially opened, in which Yingqi Zhao serves as SWOG Study Co-Primary Statistician (SWOG).
January 2025. Yingqi Zhao and collaborators published a new paper, entitled ‘Efficient surrogate-assisted inference for patient-reported outcome measures with complex missing mechanism’, in Electronic Journal of Statistics.
November 2024. Check ou this Science Spotlight article! Kehao Zhu, Yingqi Zhao and Yingye Zheng published a new paper in Biometrics offering a new approach to cancer screenign trial design. Congratulations!
July 2024. The Patient-Centered Outcomes Research Institute (PCORI) awards Yingqi Zhao a 3-year research grant. The award, titled "Improve the Design and Analysis of Randomized Screening Trials in a New Era of Cancer Early Detection," was in response to PCORI's "Improving Methods for Conducting Patient-Centered Outcomes Research" funding announcement. The study aims to develop and improve the design and analysis of randomized screening trials (RSTs) for early cancer detection. The ultimate objective is to enable more efficient and accurate trials that assess the mortality benefits of cancer screening, while also considering the potential harms, to guide informed decision-making for screening practices.